718 related articles for article (PubMed ID: 2536517)
1. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
DiGiacomo RA; Kremer JM; Shah DM
Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
[TBL] [Abstract][Full Text] [Related]
2. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
Wise RA; Malamet R; Wigley FM
J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
[TBL] [Abstract][Full Text] [Related]
4. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
[TBL] [Abstract][Full Text] [Related]
5. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome.
Mohrland JS; Porter JM; Smith EA; Belch J; Simms MH
Ann Rheum Dis; 1985 Nov; 44(11):754-60. PubMed ID: 3904643
[TBL] [Abstract][Full Text] [Related]
6. Raynaud's phenomenon of the lung.
Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
8. Role of digital artery adrenoceptors in Raynaud's disease.
Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
[TBL] [Abstract][Full Text] [Related]
9. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
Cristol R; Debray J
J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
[TBL] [Abstract][Full Text] [Related]
10. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
Lukác J; Rovenský J; Tauchmannová H; Zitnan D
Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
[TBL] [Abstract][Full Text] [Related]
11. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
Wise RA; Wigley FM; White B; Leatherman G; Zhong J; Krasa H; Kambayashi J; Orlandi C; Czerwiec FS
Arthritis Rheum; 2004 Dec; 50(12):3994-4001. PubMed ID: 15593189
[TBL] [Abstract][Full Text] [Related]
13. Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients.
Planchon B; Pistorius MA; Beurrier P; De Faucal P
Angiology; 1994 Aug; 45(8):677-86. PubMed ID: 8048777
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin in the treatment of Raynaud's phenomenon associated with generalized scleroderma.
Engelhart M
Br J Dermatol; 1988 Dec; 119(6):751-4. PubMed ID: 3060193
[TBL] [Abstract][Full Text] [Related]
15. Multifinger photoplethysmography and digital blood pressure measurement in patients with Raynaud's phenomenon of the hand.
Tordoir JH; Haeck LB; Winterkamp H; Dekkers W
J Vasc Surg; 1986 Mar; 3(3):456-61. PubMed ID: 3951030
[TBL] [Abstract][Full Text] [Related]
16. [Raynaud's syndrome: study of fingertip blood flow by plethysmography with venous occlusion (author's transl)].
Cristol R; Graisely B; Cloarec M; Debray J
Nouv Presse Med; 1979 Jan; 8(2):105-8. PubMed ID: 554069
[TBL] [Abstract][Full Text] [Related]
17. Raynaud's phenomenon in arterial occlusive disease.
Tordoir JH; Winterkamp H; Dekkers W
Neth J Surg; 1985 Aug; 37(4):97-100. PubMed ID: 4047443
[TBL] [Abstract][Full Text] [Related]
18. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon.
Walmsley D; Goodfield MJ
Br J Rheumatol; 1990 Jun; 29(3):181-4. PubMed ID: 2357499
[TBL] [Abstract][Full Text] [Related]
20. Enalapril in Raynaud's phenomenon.
Janini SD; Scott DG; Coppock JS; Bacon PA; Kendall MJ
J Clin Pharm Ther; 1988 Apr; 13(2):145-50. PubMed ID: 2839529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
